Surv BioPharma Inc.
PrivateLast Round
Series B
Extension
Dec 23, 2025
Total Funding Raised
$38.69M
Company Overview
Surv BioPharma Inc. is a biopharmaceutical company that develops oncolytic viruses and in vivo gene therapies for cancers and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Surv BioPharma Inc. Comps
Public and private peers based on sector, stage, and business model.
Surv BioPharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 23, 2025 | ||||
| Grant | Dec 4, 2025 | ||||
| Series B | Nov 11, 2025 | ||||
| Seed | Dec 28, 2022 |
Surv BioPharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Japan Agency for Medical Research and Development | Grant |
| Tokai Tokyo Investment Co., Ltd. | Series B |
| Keio Innovation Initiative | Series B |
| Oita Venture Capital Co., Ltd. | Series B Extension |
| 日本ベンチャーキャピタル株式会社 | Series B |
| Kagoshima Development Co., Ltd. | Seed, Series B |
| 株式会社FFGベンチャービジネスパートナーズ | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 23, 2025
$4.3M round with participation from TOHO HOLDINGS.
- Dec 4, 2025
$17.3M grant from Japan Agency for Medical Research and Development.
Surv BioPharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Surv BioPharma Inc.'s valuation, stock price, and market status.
